Highlights and Quick Summary
- Preferred Stock (Total) for the quarter ending June 30, 2020 was $0 (a NaN% decrease compared to previous quarter)
- Year-over-year quarterly Preferred Stock (Total) decreased by NaN%
- Annual Preferred Stock (Total) for 2019 was $27.4 Million
Visit stockrow.com/DYN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Preferred Stock (Total) of Dyne Therapeutics, Inc.
Most recent Preferred Stock (Total)of DYN including historical data for past 10 years.Interactive Chart of Preferred Stock (Total) of Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc. Preferred Stock (Total) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2020 | – | – | $0.0 | $0.0 | – |
| 2019 | $27.43 | $0.0 | – | – | $27.43 |
Business Profile of Dyne Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology